Aceto, a firm marketing, selling and distributing health and pharmaceuticals products, will sell its chemicals division to a New York private equity firm for $411 million, according to Newsday.
Pharmacy
Johnson & Johnson said as many as 800 healthcare centers are approved to administer its ketamine-like antidepressant, which was approved by the FDA last month, according to CNBC.
Accredo, Express Scripts' specialty pharmacy, will open a new location in Honolulu, according to the St. Louis Business Journal.
Amgen's new osteoporosis drug Evenity will launch at a price of $1,825 per month or $21,900 annually, according to Reuters.
Insys Therapeutics, the troubled fentanyl spray maker, has replaced its CEO.
Advertisement
The U.S. Supreme Court declined to hear Allergan's appeal defending its effort to shield its patents from review by selling them to a Native American tribe, according to STAT. The rebuff leaves a lower court ruling in place.
CVS Health will pay $535,000 to resolve allegations that some of its pharmacies in Rhode Island filled dozens of forged prescriptions, according to local TV broadcaster WPRI.
Rutland Pharmacy, an independent pharmacy in Vermont, is suing a New York insurer, MVP Health Care, for pushing its customers to use a mail order pharmacy to fill prescriptions, according to the Burlington Free Press.
Achaogen, a biopharmaceutical company based in South San Francisco, Calif., filed for Chapter 11 bankruptcy April 15.
Nationwide Children's Hospital in Columbus, Ohio, has quietly become a go-to hub for gene therapy research and production, according to Xconomy National.